Researchers randomly assigned participants to 4mg, 9mg and 12mg dosing groups and a placebo group
As clinicians continue to address the growing overlap between obesity, diabetes, and chronic pain, GLP-1 therapies are attracting attention as a potentially broader metabolic intervention
Further details can be found in electronic supplementary material (ESM) Methods
Personalized GLP-1 Selection Through Genetic Testing PlexusDx offers the Precision Peptide Genetic Test ($298), which analyzes key genetic variants that influence GLP-1 receptor sensitivity, appetite regulation, and metabolic response
However, using a 7.2 mg dose showed weight loss of up to 18% at week 48, suggesting that higher doses of semaglutide may help close the gap with other medications